Where Science, Strategy, and Engagement Converge
+40
Successful Deliveries Over 15 Years
Translating complex clinical and scientific content into tailored, compliant digital experiences for KOLs, HCPs, and patient audiences across Medical Affairs and Commercial, with 10+ years supporting Fortune 500 healthcare brands and high-growth startups.

Storytelling for Pharma and Healthcare
Over the years, I have had the opportunity to collaborate with some leading market leaders across, pharmaceutical, healthcare, life sciences, and medical device companies to craft digital solutions for…
READ MORE →

Adding immersive learning to the scientific space
We developed a highly immersive interactive cinematic scene that showed the mechanism of disease for Lupus Nephritis and a proposed therapy…
READ MORE →

Interactivity for Pharma, Healthcare, and Lifesciences
Having spent years as a creative executive for a small but bustling digital production agency I worked with clients and their agencies of record to design, produce, and deploy…
READ MORE →
Capabilities
Aligning scientific storytelling, stakeholder engagement, and data-driven insights to create cohesive experiences that accelerate understanding, build credibility, and drive meaningful action across healthcare audiences.
Strategy and Planning
Brand & Message Audit
Scientific Exchange Materials
MSL Decks and Training Tools
Congress Presense
KOL Engagement Strategy
Advisory Board and Investor Material
Develop Creative Collateral
Scientific Narrative Development
Data Storytelling
Collateral Creative Services
Web & Digital Tools Development
Graphic & Media Production
Deliver Reportable Success
Scientific & Medical Analytics
Lead Capture Systems & Process
508 / ADA Compliance
CMS / DAM Ecosystem
SEO, SERP, AI-search Optimizations
FROM OUR PORTFOLIO
Congress educational tactics and day-to-day collateral
At the commercial launch of Biogen Idec’s Fampyra, we created an interactive eDetail designed to translate complex science into meaningful engagement. Beginning with an award-winning mechanism of disease video, the work evolved into a mechanism of action experience post-FDA approval, and expanded into a compelling educational tool for congress settings. From there, it grew into a robust ecosystem of collateral—pathway graphics, poster support materials, and more—ultimately becoming a go-to resource for MSLs in the field.







